STOCK TITAN

Bright Minds Biosciences: Cormorant reports 8.11% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Bright Minds Biosciences Inc. (DRUG) is the issuer named in Amendment No. 5, in which Cormorant Asset Management, LP and Bihua Chen each report beneficial ownership of 800,000 common shares, or 8.11%. Both report shared voting and dispositive power over those shares and no sole voting or dispositive power; the shares are directly held by Cormorant Funds. The percentage is calculated using 9,864,061 common shares outstanding as of August 13, 2026. The reporting persons state the report is not an admission of beneficial ownership for Section 13 purposes.

Beneficial ownership reported 800,000 common shares Cormorant Asset Management, LP and Bihua Chen each report this amount.
Percentage of class 8.11% Reported by each reporting person.
Issuer common shares outstanding 9,864,061 shares As of August 13, 2026; used to calculate the reported ownership percentages.
beneficially owned regulatory
"Amount beneficially owned: 800,000"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared voting power over 800,000 shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power over 800,000 shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Bright Minds Biosciences (DRUG) shares do Cormorant Asset Management and Bihua Chen report?

Each reports beneficial ownership of 800,000 common shares, or 8.11%, with shared voting and dispositive power over those shares.

Which fund has dividend or sale-proceeds rights in more than 5% of DRUG?

Cormorant Global Healthcare Master Fund, LP has the right to receive or direct the receipt of dividends or proceeds from the sale of more than 5% of the shares reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





10919W405

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Cormorant Asset Management, LP
Signature:/s/ Bihua Chen
Name/Title:Bihua Chen, Managing Member
Date:11/16/2026
Bihua Chen
Signature:/s/ Bihua Chen
Name/Title:Bihua Chen
Date:11/16/2026
Exhibit Information

Joint Filing Statement, incorporated by reference to the Joint Filing Statement included with the Schedule 13G filed by the Reporting Persons on October 22, 2024.

Keep reading